COVID-19 management: What we need to know?

Introduction The world is plagued by the COVID-19 pandemic. This is an unprecedented situation in the modern era wherein we do not know our enemy in detail. In fact, we hardly know anything. We have just started to learn about COVID-19; the management guidelines are evolving and are mostly consensus based at present, rather than randomized data. In this article, we will briefly review some important updates and evolving research in the management of COVID-19. Publication History Received: 25 April 2020 Accepted: 01 May 2020 Article published online: 17 May 2021 © 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Abstract licence: CC BY

1. 7.

   In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) · 2020

2. 19.

   Effectiveness of convalescent plasma therapy in severe COVID-19 patients · 2020

21 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.